Sort by
Refine Your Search
-
headquarters in Kendall Square, the group is building a sustainable innovation engine within the biotech community. Ipsen Biopharmaceuticals, Inc., in conjunction with Northeastern University, is sponsoring two
-
values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to
-
with existing partners on on-going projects and building new relationships with local government agencies and community and non-profit organizations. (30%) All candidates will be expected to conduct
-
this knowledge can make translational impact and improve society. Additional Information Northeastern has a comprehensive benefits package for benefit eligible employees. This includes medical, vision, dental
-
analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure (SBS-IF), as well as several earlier stage assets. Building upon our history of GI
-
comprehensive, focused experience in the biopharmaceutical industry. Experience gained while working within our US Commercial teams will help prepare the fellow(s) to make a sustainable contribution in support of
-
of expertise outside clinical development according to your interests. The intent of this program is to train you in across different Clinical Development functions and build a foundation for clinical trials
-
, identify data gaps & new publication opportunities, build scientific platform/product lexicon, omnichannel communications Medical Strategy: Sample projects: Medical affairs strategic planning + execution
-
new applications. Qualifications: Must have a PhD or equivalent in engineering or mathematics. Must be able to undertake full-time research and scholarship. Must be able to work in collaborative multi
-
-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure (SBS-IF), as well as several earlier stage assets. Building upon our